Efficacy and safety of JAK inhibitors in connective tissue disease-associated interstitial lung disease

Efficacy and safety of JAK inhibitors in connective tissue disease-associated interstitial lung disease

Saved in:

Bibliographic Details
Main Authors:	Jiajia Wu, Chunli Mei, Zhijun Luo, Xujing Yuan, Wenxun Lin, Rong Du, Xiangxiang Pan
Format:	Article
Language:	English
Published:	Wolters Kluwer 2025-01-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000003359
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Management of connective tissue disease-associated interstitial lung disease
by: Keerthi Talari
Published: (2021-01-01)

Imaging in connective tissue disease-associated interstitial lung disease
by: Praveen P G. Rao, et al.
Published: (2021-01-01)

Diagnosis and Management of Interstitial Lung Disease in Patients with Connective Tissue Diseases
by: Matthew Koslow, et al.
Published: (2021-01-01)

Updates in the management of connective tissue disease-associated interstitial lung disease
by: Chengappa Kavadichanda, et al.
Published: (2021-01-01)

Comparison of Characteristics of Connective Tissue Disease-Associated Interstitial Lung Diseases, Undifferentiated Connective Tissue Disease-Associated Interstitial Lung Diseases, and Idiopathic Pulmonary Fibrosis in Chinese Han Population: A Retrospective Study
by: Lin Pan, et al.
Published: (2013-01-01)

Connective tissue disease-associated interstitial lung disease – A multicenter observational study from India
by: Sham Santhanam, et al.
Published: (2021-01-01)

Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study
by: Adeline Ruyssen-Witrand, et al.
Published: (2025-01-01)

Descriptive study of the role of ultrasound in the evaluation of patients with interstitial lung disease associated with autoimmune connective tissue disorders
by: Varghese Koshy, et al.
Published: (2023-01-01)

Interstitial lung disease in rheumatic diseases
by: Sham Santhanam, et al.
Published: (2021-01-01)

Granulomatous Lymphocytic Interstitial Lung Disease in Infancy
by: Adetayo Adeleye, et al.
Published: (2014-01-01)

Assessment and follow-up of interstitial lung disease
by: Devarasetti Phani Kumar
Published: (2021-01-01)

Methotrexate does not cause interstitial lung disease
by: Anand Narayan Malaviya
Published: (2020-01-01)

Cancer therapy-related interstitial lung disease
by: Chengzhi Zhou, et al.
Published: (2025-02-01)

Efficacy and safety of antifibrotic drugs for interstitial lung diseases other than IPF: A systematic review, meta-analysis and trial sequential analysis.
by: Mei Yang, et al.
Published: (2025-01-01)

Serum KL-6 levels reflect the severity of interstitial lung disease caused by immune checkpoint inhibitors
by: Xiaoping Li, et al.
Published: (2025-01-01)

Antisynthetase Syndrome with Severe Interstitial Lung Disease in Pregnancy
by: Catalina I. Dumitrascu, et al.
Published: (2021-01-01)

Picking interstitial lung disease out of the myositis haystack
by: Jennifer Hannah, et al.
Published: (2020-01-01)

Efficacy and safety of conventional synthetic, biologic, and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis-interstitial lung disease: A narrative review
by: Richard Conway, et al.
Published: (2021-01-01)

Pediatric Interstitial Lung Disease Masquerading as Difficult Asthma: Management Dilemmas for Rare Lung Disease in Children
by: EY Chan, et al.
Published: (2005-01-01)

Challenges in the Diagnosis and Management of Patients with Fibrosing Interstitial Lung Disease
by: Leslie B. Tolle
Published: (2022-01-01)

The evolving spectrum of interstitial lung disease in myositis—Management pearls
by: Takahisa Gono
Published: (2020-01-01)

The Hyperactivation of JAK-STAT Signaling Connects Inborn Errors of Immunity and Autoimmune Diseases
by: JIANG Yi, et al.
Published: (2024-10-01)

Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis
by: Argyris Tzouvelekis, et al.
Published: (2012-01-01)

A rare cause of anti-nucleolar (Th/To) antibody seropositivity in interstitial pneumonia with autoimmune features/undifferentiated connective tissue disease
by: Chhabra Seema, et al.
Published: (2023-07-01)

Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?
by: Beatrice Maranini, et al.
Published: (2025-01-01)

Vasoreactivity and inhaled treprostinil response in interstitial lung disease pulmonary hypertension
by: Eileen M. Harder, et al.
Published: (2024-12-01)

The role of pulmonary function tests in the management of patients with connective tissue diseases and lung involvement
by: Piotr W. Boros
Published: (2024-11-01)

Calcinosis cutis in connective tissue diseases
by: Gianfranco Vitiello, et al.
Published: (2018-01-01)

The Impact of Multidisciplinary Discussion (MDD) in the Diagnosis and Management of Fibrotic Interstitial Lung Diseases
by: Ghofran Ageely, et al.
Published: (2020-01-01)

Oral manifestations of autoimmune connective tissue diseases
by: Akshat Pandey, et al.
Published: (2018-01-01)

Pulmonary hypertension associated with connective tissue disease
by: Srinivas Rajagopala, et al.
Published: (2017-01-01)

Colorectal Perforation in Patients with Connective Tissue Disease
by: Kiichi Sugimoto, et al.
Published: (2019-01-01)

Supporting self-management for patients with Interstitial Lung Diseases: Utility and acceptability of digital devices.
by: Malik A Althobiani, et al.
Published: (2024-01-01)

Neutrophil extracellular traps (NETs) are increased in rheumatoid arthritis-associated interstitial lung disease
by: Jing Xue, et al.
Published: (2025-01-01)

Pulmonary Hemodynamics and Six-Minute Walk Test Outcomes in Patients with Interstitial Lung Disease
by: Osamu Nishiyama, et al.
Published: (2016-01-01)

Proteome-wide mendelian randomization identifies causal plasma proteins in interstitial lung disease
by: Kunrong Yu, et al.
Published: (2025-01-01)

Mucosal Epithelial Jak Kinases in Health and Diseases
by: Narendra Kumar, et al.
Published: (2021-01-01)

Warrick score in rheumatoid-arthritis interstitial lung disease: a promising tool for assessing the extent and progression of lung involvement
by: Duygu Temiz Karadag, et al.
Published: (2025-01-01)

Role of Oxidants in Interstitial Lung Diseases: Pneumoconioses, Constrictive Bronchiolitis, and Chronic Tropical Pulmonary Eosinophilia
by: William N. Rom
Published: (2011-01-01)

Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease in Women with Rheumatoid Arthritis
by: Alberto Daniel Rocha-Muñoz, et al.
Published: (2015-01-01)